KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Bio-Rad Laboratories (BIO) over the last 14 years, with Q4 2025 value amounting to $1.0 billion.

  • Bio-Rad Laboratories' Treasury Shares rose 3076.03% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 3076.03%. This contributed to the annual value of $1.0 billion for FY2025, which is 3076.03% up from last year.
  • As of Q4 2025, Bio-Rad Laboratories' Treasury Shares stood at $3.3 million, which was up 4527.14% from $3.3 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Treasury Shares ranged from a high of $4.1 million in Q2 2025 and a low of $244548.0 during Q2 2021
  • For the 5-year period, Bio-Rad Laboratories' Treasury Shares averaged around $1.6 million, with its median value being $1.5 million (2023).
  • Over the last 5 years, Bio-Rad Laboratories' Treasury Shares had its largest YoY gain of 14798.76% in 2022, and its largest YoY loss of 2909.51% in 2022.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Treasury Shares stood at $106.3 million in 2021, then skyrocketed by 147.99% to $263.6 million in 2022, then skyrocketed by 139.96% to $632.5 million in 2023, then increased by 22.07% to $772.1 million in 2024, then surged by 30.76% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q4 2025, $1.0 billion for Q3 2025, and $1.0 billion during Q2 2025.